Medical Sciences
Global

Medical Sciences Experts

Michael Gross

Director
Molecular Imaging
Delphinus Medical Technologies, Inc.
United States of America

Biography

 Mr. Gross is Managing Director at Beringea, LLC and is responsible for investment sourcing, deal execution and portfolio management, with a focus on healthcare, technology enabled services, and sustainability. He joined the Board of Directors for Delphinus Medical Technologies in 2010. Within the Beringea portfolio of companies, he serves on the boards of Molecular Imaging, InTouch Health, Intervention Insights, Xanitos, Freeosk, and Fiber By-Products, and is a board observer for MedVantx. Previous portfolio companies include Pioneer Surgical Technology (acquired by RTI Biologics), Relume Technology (acquired by Revolution Lighting), and Ecosynthetix (TSX: ECO). Prior to joining Beringea, Mr. Gross was vice president of investment banking with P&M Corporate Finance as well as the investment banking group at Stout Risius Ross, Inc. He is a CFA charterholder and earned a B.A. in Finance from Michigan State University.

Research Interest

 Management,Healthcare, Technology,Molecular Imaging

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
View more